Listed

Ovid Therapeutics Inc.

OVIDNasdaqCIK 1636651HealthcareFiscal year ends Dec 31

Share

Share this page

Story card, 1080 × 1920

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$733.0k, Q2 FY2026
Operating income−$15.7m, Q2 FY2026
Net income−$15.0m, Q2 FY2026
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$m0.1Revenue, Q3 FY2023, three months to 2023-09-30$109.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2024-11-12, accession 0001628280-24-046868.Report this figure0.1Revenue, Q4 FY2023, three months to 2023-12-31$142.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-03-11, accession 0001628280-25-011844. Derived: 12-month figure less the 9-month figure.Report this figure0.1Revenue, Q1 FY2024, three months to 2024-03-31$148.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-05-13, accession 0001628280-25-024913.Report this figure0.2Revenue, Q2 FY2024, three months to 2024-06-30$169.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-08-13, accession 0001628280-25-040008.Report this figure0.2Revenue, Q3 FY2024, three months to 2024-09-30$173.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-12, accession 0001636651-25-000012.Report this figure0.1Revenue, Q4 FY2024, three months to 2024-12-31$76.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-18, accession 0001628280-26-019438. Derived: 12-month figure less the 9-month figure.Report this figure0.1Revenue, Q1 FY2025, three months to 2025-03-31$130.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-12, accession 0001628280-26-033864.Report this figure6.3Revenue, Q2 FY2025, three months to 2025-06-30$6.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-13, accession 0001628280-26-056498.Report this figure0.1Revenue, Q3 FY2025, three months to 2025-09-30$132.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-12, accession 0001636651-25-000012.Report this figure0.7Revenue, Q4 FY2025, three months to 2025-12-31$718.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-18, accession 0001628280-26-019438. Derived: 12-month figure less the 9-month figure.Report this figure0.0Revenue, Q1 FY2026, three months to 2026-03-31$0. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-12, accession 0001628280-26-033864.Report this figure0.7Revenue, Q2 FY2026, three months to 2026-06-30$733.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-13, accession 0001628280-26-056498.Report this figure
Research and development$m5.3Research and development, Q3 FY2023, three months to 2023-09-30$5.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-12, accession 0001628280-24-046868.Report this figure10.6Research and development, Q4 FY2023, three months to 2023-12-31$10.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-03-11, accession 0001628280-25-011844. Derived: 12-month figure less the 9-month figure.Report this figure10.4Research and development, Q1 FY2024, three months to 2024-03-31$10.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-13, accession 0001628280-25-024913.Report this figure12.6Research and development, Q2 FY2024, three months to 2024-06-30$12.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-13, accession 0001628280-25-040008.Report this figure7.9Research and development, Q3 FY2024, three months to 2024-09-30$7.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-12, accession 0001636651-25-000012.Report this figure5.9Research and development, Q4 FY2024, three months to 2024-12-31$5.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-18, accession 0001628280-26-019438. Derived: 12-month figure less the 9-month figure.Report this figure6.7Research and development, Q1 FY2025, three months to 2025-03-31$6.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-12, accession 0001628280-26-033864.Report this figure6.5Research and development, Q2 FY2025, three months to 2025-06-30$6.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-13, accession 0001628280-26-056498.Report this figure5.9Research and development, Q3 FY2025, three months to 2025-09-30$5.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-12, accession 0001636651-25-000012.Report this figure6.6Research and development, Q4 FY2025, three months to 2025-12-31$6.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-18, accession 0001628280-26-019438. Derived: 12-month figure less the 9-month figure.Report this figure11.2Research and development, Q1 FY2026, three months to 2026-03-31$11.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-12, accession 0001628280-26-033864.Report this figure10.0Research and development, Q2 FY2026, three months to 2026-06-30$10.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-13, accession 0001628280-26-056498.Report this figure
Selling, general and administrative$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Operating income$m(12.0)Operating income, Q3 FY2023, three months to 2023-09-30−$12.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-12, accession 0001628280-24-046868.Report this figure(18.2)Operating income, Q4 FY2023, three months to 2023-12-31−$18.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-11, accession 0001628280-25-011844. Derived: 12-month figure less the 9-month figure.Report this figure(17.4)Operating income, Q1 FY2024, three months to 2024-03-31−$17.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-13, accession 0001628280-25-024913.Report this figure(20.5)Operating income, Q2 FY2024, three months to 2024-06-30−$20.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-13, accession 0001628280-25-040008.Report this figure(13.2)Operating income, Q3 FY2024, three months to 2024-09-30−$13.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-12, accession 0001636651-25-000012.Report this figure(10.7)Operating income, Q4 FY2024, three months to 2024-12-31−$10.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-18, accession 0001628280-26-019438. Derived: 12-month figure less the 9-month figure.Report this figure(12.6)Operating income, Q1 FY2025, three months to 2025-03-31−$12.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-12, accession 0001628280-26-033864.Report this figure(5.1)Operating income, Q2 FY2025, three months to 2025-06-30−$5.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-13, accession 0001628280-26-056498.Report this figure(12.5)Operating income, Q3 FY2025, three months to 2025-09-30−$12.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-12, accession 0001636651-25-000012.Report this figure(12.3)Operating income, Q4 FY2025, three months to 2025-12-31−$12.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-18, accession 0001628280-26-019438. Derived: 12-month figure less the 9-month figure.Report this figure(17.8)Operating income, Q1 FY2026, three months to 2026-03-31−$17.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-12, accession 0001628280-26-033864.Report this figure(15.7)Operating income, Q2 FY2026, three months to 2026-06-30−$15.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-13, accession 0001628280-26-056498.Report this figure
Income tax$m0.0Income tax, Q3 FY2023, three months to 2023-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-11-12, accession 0001628280-24-046868.Report this figure0.0Income tax, Q4 FY2023, three months to 2023-12-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2025-03-11, accession 0001628280-25-011844. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2024, three months to 2024-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-05-13, accession 0001628280-25-024913.Report this figure0.0Income tax, Q2 FY2024, three months to 2024-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-08-13, accession 0001628280-25-040008.Report this figure0.0Income tax, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-12, accession 0001636651-25-000012.Report this figure0.0Income tax, Q4 FY2024, three months to 2024-12-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-18, accession 0001628280-26-019438. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2025, three months to 2025-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-12, accession 0001628280-26-033864.Report this figure0.0Income tax, Q2 FY2025, three months to 2025-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-13, accession 0001628280-26-056498.Report this figure0.0Income tax, Q3 FY2025, three months to 2025-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-12, accession 0001636651-25-000012.Report this figure0.0Income tax, Q4 FY2025, three months to 2025-12-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-18, accession 0001628280-26-019438. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2026, three months to 2026-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-12, accession 0001628280-26-033864.Report this figure0.0Income tax, Q2 FY2026, three months to 2026-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-13, accession 0001628280-26-056498.Report this figure
Net income$m(11.3)Net income, Q3 FY2023, three months to 2023-09-30−$11.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-12, accession 0001628280-24-046868.Report this figure(15.3)Net income, Q4 FY2023, three months to 2023-12-31−$15.3m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-11, accession 0001628280-25-011844. Derived: 12-month figure less the 9-month figure.Report this figure(11.7)Net income, Q1 FY2024, three months to 2024-03-31−$11.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001636651-25-000012.Report this figure8.5Net income, Q2 FY2024, three months to 2024-06-30$8.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001636651-25-000012.Report this figure(14.0)Net income, Q3 FY2024, three months to 2024-09-30−$14.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001636651-25-000012.Report this figure(9.3)Net income, Q4 FY2024, three months to 2024-12-31−$9.3m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-18, accession 0001628280-26-019438. Derived: 12-month figure less the 9-month figure.Report this figure(10.2)Net income, Q1 FY2025, three months to 2025-03-31−$10.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001628280-26-056498.Report this figure(4.7)Net income, Q2 FY2025, three months to 2025-06-30−$4.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001628280-26-056498.Report this figure(12.2)Net income, Q3 FY2025, three months to 2025-09-30−$12.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001636651-25-000012.Report this figure9.7Net income, Q4 FY2025, three months to 2025-12-31$9.7m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-18, accession 0001628280-26-019438. Derived: 12-month figure less the 9-month figure.Report this figure(17.0)Net income, Q1 FY2026, three months to 2026-03-31−$17.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001628280-26-056498.Report this figure(15.0)Net income, Q2 FY2026, three months to 2026-06-30−$15.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001628280-26-056498.Report this figure
Diluted EPS$ per share(0.16)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$0.16 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-12, accession 0001628280-24-046868.Report this figurenot reported(0.17)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$0.17 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-05-14, accession 0001628280-24-023067.Report this figure0.12Diluted EPS, Q2 FY2024, three months to 2024-06-30$0.12 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-08-13, accession 0001628280-24-036860.Report this figure(0.20)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$0.20 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-12, accession 0001628280-24-046868.Report this figurenot reportednot reportednot reportednot reportednot reportednot reportednot reported
Basic EPS$ per share(0.16)Basic EPS, Q3 FY2023, three months to 2023-09-30−$0.16 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-12, accession 0001628280-24-046868.Report this figurenot reported(0.17)Basic EPS, Q1 FY2024, three months to 2024-03-31−$0.17 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-05-14, accession 0001628280-24-023067.Report this figure0.12Basic EPS, Q2 FY2024, three months to 2024-06-30$0.12 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-08-13, accession 0001628280-24-036860.Report this figure(0.20)Basic EPS, Q3 FY2024, three months to 2024-09-30−$0.20 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-12, accession 0001628280-24-046868.Report this figurenot reportednot reportednot reportednot reportednot reportednot reportednot reported

Balance sheet

Cash and equivalents$11.3m, Q2 FY2026
Shareholders' equity$209.9m, Q2 FY2026
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m57.4Cash and equivalents, Q3 FY2023, at 2023-09-30$57.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2023-11-03, accession 0001628280-23-036564.Report this figure27.0Cash and equivalents, FY2023, at 2023-12-31$27.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-03-11, accession 0001628280-25-011844.Report this figure30.8Cash and equivalents, Q1 FY2024, at 2024-03-31$30.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-05-14, accession 0001628280-24-023067.Report this figure29.7Cash and equivalents, Q2 FY2024, at 2024-06-30$29.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-08-13, accession 0001628280-24-036860.Report this figure15.0Cash and equivalents, Q3 FY2024, at 2024-09-30$15.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-12, accession 0001628280-24-046868.Report this figure26.3Cash and equivalents, FY2024, at 2024-12-31$26.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-18, accession 0001628280-26-019438.Report this figure21.1Cash and equivalents, Q1 FY2025, at 2025-03-31$21.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-13, accession 0001628280-25-024913.Report this figure28.4Cash and equivalents, Q2 FY2025, at 2025-06-30$28.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-13, accession 0001628280-25-040008.Report this figure20.6Cash and equivalents, Q3 FY2025, at 2025-09-30$20.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-12, accession 0001636651-25-000012.Report this figure13.2Cash and equivalents, FY2025, at 2025-12-31$13.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-13, accession 0001628280-26-056498.Report this figure94.1Cash and equivalents, Q1 FY2026, at 2026-03-31$94.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-12, accession 0001628280-26-033864.Report this figure11.3Cash and equivalents, Q2 FY2026, at 2026-06-30$11.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-13, accession 0001628280-26-056498.Report this figure
Current assets$m91.7Current assets, Q3 FY2023, at 2023-09-30$91.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-03, accession 0001628280-23-036564.Report this figure110Current assets, FY2023, at 2023-12-31$109.6m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-11, accession 0001628280-25-011844.Report this figure93.2Current assets, Q1 FY2024, at 2024-03-31$93.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-14, accession 0001628280-24-023067.Report this figure80.9Current assets, Q2 FY2024, at 2024-06-30$80.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-13, accession 0001628280-24-036860.Report this figure65.8Current assets, Q3 FY2024, at 2024-09-30$65.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-12, accession 0001628280-24-046868.Report this figure55.9Current assets, FY2024, at 2024-12-31$55.9m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-18, accession 0001628280-26-019438.Report this figure45.9Current assets, Q1 FY2025, at 2025-03-31$45.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-13, accession 0001628280-25-024913.Report this figure42.1Current assets, Q2 FY2025, at 2025-06-30$42.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-13, accession 0001628280-25-040008.Report this figure28.8Current assets, Q3 FY2025, at 2025-09-30$28.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-12, accession 0001636651-25-000012.Report this figure74.4Current assets, FY2025, at 2025-12-31$74.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-13, accession 0001628280-26-056498.Report this figure160Current assets, Q1 FY2026, at 2026-03-31$160.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-12, accession 0001628280-26-033864.Report this figure124Current assets, Q2 FY2026, at 2026-06-30$123.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-13, accession 0001628280-26-056498.Report this figure
Total assets$m125Total assets, Q3 FY2023, at 2023-09-30$125.0m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-03, accession 0001628280-23-036564.Report this figure144Total assets, FY2023, at 2023-12-31$144.0m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-11, accession 0001628280-25-011844.Report this figure132Total assets, Q1 FY2024, at 2024-03-31$131.6m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-14, accession 0001628280-24-023067.Report this figure118Total assets, Q2 FY2024, at 2024-06-30$118.1m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-13, accession 0001628280-24-036860.Report this figure103Total assets, Q3 FY2024, at 2024-09-30$102.7m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-12, accession 0001628280-24-046868.Report this figure92.2Total assets, FY2024, at 2024-12-31$92.2m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-18, accession 0001628280-26-019438.Report this figure81.7Total assets, Q1 FY2025, at 2025-03-31$81.7m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-13, accession 0001628280-25-024913.Report this figure77.4Total assets, Q2 FY2025, at 2025-06-30$77.4m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-13, accession 0001628280-25-040008.Report this figure63.8Total assets, Q3 FY2025, at 2025-09-30$63.8m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-12, accession 0001636651-25-000012.Report this figure151Total assets, FY2025, at 2025-12-31$150.9m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-13, accession 0001628280-26-056498.Report this figure226Total assets, Q1 FY2026, at 2026-03-31$225.6m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-12, accession 0001628280-26-033864.Report this figure232Total assets, Q2 FY2026, at 2026-06-30$232.0m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-13, accession 0001628280-26-056498.Report this figure
Current liabilities$m8.7Current liabilities, Q3 FY2023, at 2023-09-30$8.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-03, accession 0001628280-23-036564.Report this figure11.5Current liabilities, FY2023, at 2023-12-31$11.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-11, accession 0001628280-25-011844.Report this figure8.9Current liabilities, Q1 FY2024, at 2024-03-31$8.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-14, accession 0001628280-24-023067.Report this figure14.1Current liabilities, Q2 FY2024, at 2024-06-30$14.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-13, accession 0001628280-24-036860.Report this figure11.6Current liabilities, Q3 FY2024, at 2024-09-30$11.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-12, accession 0001628280-24-046868.Report this figure10.5Current liabilities, FY2024, at 2024-12-31$10.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-18, accession 0001628280-26-019438.Report this figure9.3Current liabilities, Q1 FY2025, at 2025-03-31$9.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-13, accession 0001628280-25-024913.Report this figure8.9Current liabilities, Q2 FY2025, at 2025-06-30$8.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-13, accession 0001628280-25-040008.Report this figure6.8Current liabilities, Q3 FY2025, at 2025-09-30$6.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-12, accession 0001636651-25-000012.Report this figure8.3Current liabilities, FY2025, at 2025-12-31$8.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-13, accession 0001628280-26-056498.Report this figure15.7Current liabilities, Q1 FY2026, at 2026-03-31$15.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-12, accession 0001628280-26-033864.Report this figure10.0Current liabilities, Q2 FY2026, at 2026-06-30$10.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-13, accession 0001628280-26-056498.Report this figure
Total liabilities$m23.7Total liabilities, Q3 FY2023, at 2023-09-30$23.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-03, accession 0001628280-23-036564.Report this figure56.2Total liabilities, FY2023, at 2023-12-31$56.2m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-11, accession 0001628280-25-011844.Report this figure53.3Total liabilities, Q1 FY2024, at 2024-03-31$53.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-14, accession 0001628280-24-023067.Report this figure29.2Total liabilities, Q2 FY2024, at 2024-06-30$29.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-13, accession 0001628280-24-036860.Report this figure26.4Total liabilities, Q3 FY2024, at 2024-09-30$26.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-12, accession 0001628280-24-046868.Report this figure23.9Total liabilities, FY2024, at 2024-12-31$23.9m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-18, accession 0001628280-26-019438.Report this figure22.4Total liabilities, Q1 FY2025, at 2025-03-31$22.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-13, accession 0001628280-25-024913.Report this figure21.6Total liabilities, Q2 FY2025, at 2025-06-30$21.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-13, accession 0001628280-25-040008.Report this figure19.2Total liabilities, Q3 FY2025, at 2025-09-30$19.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-12, accession 0001636651-25-000012.Report this figure20.3Total liabilities, FY2025, at 2025-12-31$20.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-13, accession 0001628280-26-056498.Report this figure27.4Total liabilities, Q1 FY2026, at 2026-03-31$27.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-12, accession 0001628280-26-033864.Report this figure22.1Total liabilities, Q2 FY2026, at 2026-06-30$22.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-13, accession 0001628280-26-056498.Report this figure
Shareholders' equity$m101Shareholders' equity, Q3 FY2023, at 2023-09-30$101.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-12, accession 0001628280-24-046868.Report this figure87.8Shareholders' equity, FY2023, at 2023-12-31$87.8m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-18, accession 0001628280-26-019438.Report this figure78.3Shareholders' equity, Q1 FY2024, at 2024-03-31$78.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001636651-25-000012.Report this figure88.9Shareholders' equity, Q2 FY2024, at 2024-06-30$88.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001636651-25-000012.Report this figure76.3Shareholders' equity, Q3 FY2024, at 2024-09-30$76.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001636651-25-000012.Report this figure68.2Shareholders' equity, FY2024, at 2024-12-31$68.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001628280-26-056498.Report this figure59.3Shareholders' equity, Q1 FY2025, at 2025-03-31$59.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001628280-26-056498.Report this figure55.8Shareholders' equity, Q2 FY2025, at 2025-06-30$55.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001628280-26-056498.Report this figure44.7Shareholders' equity, Q3 FY2025, at 2025-09-30$44.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001636651-25-000012.Report this figure131Shareholders' equity, FY2025, at 2025-12-31$130.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001628280-26-056498.Report this figure198Shareholders' equity, Q1 FY2026, at 2026-03-31$198.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001628280-26-056498.Report this figure210Shareholders' equity, Q2 FY2026, at 2026-06-30$209.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001628280-26-056498.Report this figure

Cash flow

Operating cash flow−$17.6m, Q2 FY2026
Capital expenditure$0, Q4 FY2025
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(10.1)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$10.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-12, accession 0001628280-24-046868. Derived: 9-month figure less the 6-month figure.Report this figure(11.9)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$11.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-11, accession 0001628280-25-011844. Derived: 12-month figure less the 9-month figure.Report this figure(16.7)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$16.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-13, accession 0001628280-25-024913.Report this figure(14.3)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$14.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-13, accession 0001628280-25-040008. Derived: 6-month figure less the 3-month figure.Report this figure(15.0)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$15.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-12, accession 0001636651-25-000012. Derived: 9-month figure less the 6-month figure.Report this figure(10.0)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$10.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-18, accession 0001628280-26-019438. Derived: 12-month figure less the 9-month figure.Report this figure(10.3)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$10.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-12, accession 0001628280-26-033864.Report this figure(4.8)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$4.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-13, accession 0001628280-26-056498. Derived: 6-month figure less the 3-month figure.Report this figure(12.9)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$12.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-12, accession 0001636651-25-000012. Derived: 9-month figure less the 6-month figure.Report this figure(10.4)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$10.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-18, accession 0001628280-26-019438. Derived: 12-month figure less the 9-month figure.Report this figure(13.9)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$13.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-12, accession 0001628280-26-033864.Report this figure(17.6)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$17.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-13, accession 0001628280-26-056498. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m0.0Capital expenditure, Q3 FY2023, three months to 2023-09-30$6.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-12, accession 0001628280-24-046868. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, Q4 FY2023, three months to 2023-12-31$13.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-03-11, accession 0001628280-25-011844. Derived: 12-month figure less the 9-month figure.Report this figure0.0Capital expenditure, Q1 FY2024, three months to 2024-03-31$19.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-13, accession 0001628280-25-024913.Report this figure0.0Capital expenditure, Q2 FY2024, three months to 2024-06-30$34.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-13, accession 0001628280-25-040008. Derived: 6-month figure less the 3-month figure.Report this figure(0.0)Capital expenditure, Q3 FY2024, three months to 2024-09-30−$4.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-12, accession 0001636651-25-000012. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, Q4 FY2024, three months to 2024-12-31$22.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-18, accession 0001628280-26-019438. Derived: 12-month figure less the 9-month figure.Report this figure0.0Capital expenditure, Q1 FY2025, three months to 2025-03-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-13, accession 0001628280-25-024913.Report this figure0.0Capital expenditure, Q2 FY2025, three months to 2025-06-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-13, accession 0001628280-25-040008. Derived: 6-month figure less the 3-month figure.Report this figure0.0Capital expenditure, Q3 FY2025, three months to 2025-09-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-12, accession 0001636651-25-000012. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, Q4 FY2025, three months to 2025-12-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-18, accession 0001628280-26-019438. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reported

Shares

Diluted shares (weighted)70.98m, Q3 FY2024
Line itemUnitQ1 FY20212021-03-31Q2 FY20212021-06-30Q3 FY20212021-09-30Q1 FY20222022-03-31Q2 FY20222022-06-30Q3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30
Diluted shares (weighted)m shares66.6Diluted shares (weighted), Q1 FY2021, three months to 2021-03-3166,578,377 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2022-05-10, accession 0000950170-22-008739.Report this figure67.8Diluted shares (weighted), Q2 FY2021, three months to 2021-06-3067,818,366 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2022-08-09, accession 0001628280-22-021759.Report this figure67.9Diluted shares (weighted), Q3 FY2021, three months to 2021-09-3067,929,894 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2022-11-08, accession 0001628280-22-028772.Report this figure70.3Diluted shares (weighted), Q1 FY2022, three months to 2022-03-3170,345,828 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-05-05, accession 0001628280-23-016013.Report this figure70.4Diluted shares (weighted), Q2 FY2022, three months to 2022-06-3070,391,458 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-08-04, accession 0001628280-23-027430.Report this figure70.4Diluted shares (weighted), Q3 FY2022, three months to 2022-09-3070,430,554 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-03, accession 0001628280-23-036564.Report this figure70.5Diluted shares (weighted), Q1 FY2023, three months to 2023-03-3170,490,704 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-14, accession 0001628280-24-023067.Report this figure70.5Diluted shares (weighted), Q2 FY2023, three months to 2023-06-3070,534,181 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-13, accession 0001628280-24-036860.Report this figure70.6Diluted shares (weighted), Q3 FY2023, three months to 2023-09-3070,618,609 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-12, accession 0001628280-24-046868.Report this figure70.7Diluted shares (weighted), Q1 FY2024, three months to 2024-03-3170,716,929 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-14, accession 0001628280-24-023067.Report this figure71.2Diluted shares (weighted), Q2 FY2024, three months to 2024-06-3071,200,798 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-13, accession 0001628280-24-036860.Report this figure71.0Diluted shares (weighted), Q3 FY2024, three months to 2024-09-3070,975,778 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-12, accession 0001628280-24-046868.Report this figure

Shares outstanding: 195.30mShares outstanding, period not labelled, at 2026-08-11195,297,857 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-13, accession 0001628280-26-056498.Report this figure at Aug 11, 2026, from the cover of the 10-Q filed Aug 13, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:44 ET. Listed shows no prices and gives no investment advice.